These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1972124)

  • 1. [Plasma pharmacokinetics of roxatidine in the healthy man: correlation with gastric antisecretory effect].
    Chen WW; Kolsky H; Lewin MJ; Bonfils S
    Gastroenterol Clin Biol; 1990; 14(4):342-6. PubMed ID: 1972124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacodynamics and pharmacokinetics of multiple doses of the new H2-receptor antagonist, roxatidine acetate, in healthy men.
    Lassman HB; Ho I; Puri SK; Sabo R; Scheffler MR
    Drugs; 1988; 35 Suppl 3():53-64. PubMed ID: 2905250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of roxatidine acetate. Evidence from pharmacodynamic and clinical trials.
    Merki HS; Bender W; Labs R
    J Clin Gastroenterol; 1989; 11 Suppl 1():S20-3; discussion S24. PubMed ID: 2572621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of food-stimulated acid secretion (intragastric titration) by roxatidine acetate. Dose-response study.
    Bonfils S; Chen WW; Vatier J
    Scand J Gastroenterol Suppl; 1988; 146():135-41. PubMed ID: 2906457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of roxatidine acetate on 24-hour gastric acidity. Early evening versus bedtime administration in healthy subjects.
    Hemery P; Congard P; Galmiche JP; Bonfils S
    Drugs; 1988; 35 Suppl 3():76-81. PubMed ID: 2905253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of roxatidine acetate on 24-hour intragastric acidity. Investigations in healthy volunteers and comparison with ranitidine and placebo.
    Merki HS; Witzel L; Kaufmann D; Kempf M; Neumann J; Scheurle E; Röhmel J; Walt RP
    Drugs; 1988; 35 Suppl 3():69-75. PubMed ID: 2905252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of roxatidine in patients with renal insufficiency.
    Gladziwa U; Wagner S; Sieberth HG; Klotz U
    Br J Clin Pharmacol; 1995 Feb; 39(2):161-7. PubMed ID: 7742154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of intragastric acidity in man: modern aspects, reproducibility of intragastric pH-monitoring, and pharmacodynamic results obtained with H2-receptor antagonists.
    Merki HS; Witzel L; Kaufmann D; Kempf M; Muessig V; Neumann J; Scheurle E; Roehmel J; Walt RP
    Scand J Gastroenterol Suppl; 1988; 146():142-52. PubMed ID: 2906458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of the H(2) blocker roxatidine acetate hydrochloride in pediatric patients, in comparison with healthy adult volunteers.
    Nakamura H; Kawashima H; Azuma R; Sato I; Nagao K; Miyazawa K
    Drug Metab Pharmacokinet; 2012; 27(4):422-9. PubMed ID: 22293541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of roxatidine acetate (HOE-760) on 24-hour intragastric acidity in healthy volunteers: comparison with ranitidine and placebo.
    Merki HS; Witzel L; Kaufmann D; Kempf M; Müssig V; Neumann J; Scheurle E; Röhmel J; Walt RP
    Aliment Pharmacol Ther; 1988 Feb; 2(1):73-81. PubMed ID: 2908751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of histamine (H2)-receptor antagonists, including roxatidine, in chronic renal failure.
    Lameire N; Rosenkranz B; Brockmeier D
    Scand J Gastroenterol Suppl; 1988; 146():100-10. PubMed ID: 2906455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of combined use of roxatidine and pirenzepine on gastric secretion in humans.
    Misawa T; Chijiiwa Y; Yoshida K; Tanaka A; Kabemura T; Fujishima H; Harada N; Nawata H
    Fukuoka Igaku Zasshi; 1990 Jul; 81(7):242-6. PubMed ID: 1976580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roxatidine acetate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic potential in peptic ulcer disease and related disorders.
    Murdoch D; McTavish D
    Drugs; 1991 Aug; 42(2):240-60. PubMed ID: 1717223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of roxatidine in healthy volunteers.
    Collins JD; Pidgen AW
    Drugs; 1988; 35 Suppl 3():41-7. PubMed ID: 2905248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of roxatidine acetate on daytime and night-time peptone-stimulated gastric acid secretion.
    Hagenmüller F
    Drugs; 1988; 35 Suppl 3():65-8. PubMed ID: 2905251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of roxatidine acetate in patients with chronic liver disease.
    Tsutsumi M; Ueshima Y; Takase S
    J Gastroenterol Hepatol; 2001 Aug; 16(8):910-5. PubMed ID: 11555106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of oral administration of roxatidine acetate hydrochloride 3 hours prior to the operation on pH and volume of gastric juice].
    Kojima A; Andoh K; Shima T; Koga Y; Hashimoto Y
    Masui; 1991 Mar; 40(3):451-3. PubMed ID: 1677048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relation of the kinetics of the antisecretory effect and kinetics of blood concentration in man. Comparing cimetidine and ranitidine].
    Raoul JL; Trouvin JH; Farinotti R; Lewin MJ; Bonfils S
    Gastroenterol Clin Biol; 1989 Jun; 13(6-7):585-90. PubMed ID: 2753306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiographic assessment of nocturnal gastric juice secretion after administration of roxatidine acetate hydrochloride.
    Tanioka H; Terahara A; Sasaki Y
    Clin Ther; 1991; 13(1):22-4. PubMed ID: 1674230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roxatidine in duodenal ulcer.
    Habibullah CM; Habeeb MA; Singh SP
    J Postgrad Med; 1995; 41(3):64-5. PubMed ID: 10707717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.